NASDAQ: RPRX
Royalty Pharma PLC Stock Ownership - Who owns Royalty Pharma?

Insider buying vs selling

Have Royalty Pharma PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher HiteChair;EVP2026-09-223,927$58.93
$231.40kSell
Christopher HiteChair;EVP2026-09-2296,073$58.52
$5.62MSell
Christopher HiteChair;EVP2026-08-18100,000$59.97
$6.00MSell
Terrance P. CoyneCFO;EVP2026-08-131,772$59.14
$104.80kSell
Terrance P. CoyneCFO;EVP2026-08-139,230$58.59
$540.75kSell
Marshall UristEVP Research Investments2026-07-019,099$55.88
$508.45kSell
Bonnie L. BasslerDirector2026-06-30689$54.40
$37.48kBuy
Christopher HiteEVP Chairman Partnering2026-06-30600$57.09
$34.25kSell
Christopher HiteEVP Chairman Partnering2026-06-3029,400$56.44
$1.66MSell
Christopher HiteEVP Chairman Partnering2026-06-302,554$57.10
$145.84kSell

1 of 8

RPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPRX insiders and whales buy or sell their stock.

RPRX Shareholders

What type of owners hold Royalty Pharma PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adage Capital Partners GP LLC6.73%38,714,280$2.26BInsider
1978 Sicaf Sif Sa 1. Gg3.84%22,081,156$1.29BInsider
1978 Sicaf Sif Sa Gg3.73%21,426,170$1.25BInsider
Pablo G. Legorreta1.48%8,526,570$497.01MInsider
William E. Ford0.71%4,086,134$238.18MInsider
Mario Germano Giuliani0.61%3,535,267$206.07MInsider
Rory B. Riggs0.27%1,533,296$89.38MInsider
James F. Reddoch0.15%845,830$49.30MInsider
George W. Lloyd0.14%779,915$45.46MInsider
Christopher Hite0.13%753,000$43.89MInsider

1 of 3

RPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPRX0.06%17.99%Net SellingNet Selling
ALNY0.10%20.79%Net Selling
ONC0.00%30.90%Net SellingNet Selling
ROIV0.08%92.24%Net SellingNet Selling
INSM0.10%17.38%Net SellingNet Selling

Royalty Pharma Stock Ownership FAQ

Who owns Royalty Pharma?

Royalty Pharma (NASDAQ: RPRX) is owned by 0.06% institutional shareholders, 17.99% Royalty Pharma insiders, and 81.95% retail investors. Adage Capital Partners GP LLC is the largest individual Royalty Pharma shareholder, owning 38.71M shares representing 6.73% of the company. Adage Capital Partners GP LLC's Royalty Pharma shares are currently valued at $2.25B.

If you're new to stock investing, here's how to buy Royalty Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.